| Role |
Name |
Disclosure |
Details |
| Author | Stephen T Gancher, MD, Adjunct Associate Professor, Department of Neurology, Oregon Health Sciences University | Nothing to disclose | Details | | Medical Editor | Daniel H Jacobs, MD, Clinical Associate Professor, Department of Neurology, University of Florida | Teva Pharmaceutical Biogen Idex Serono EMD Pfizer Berlex | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Nestor Galvez-Jimenez, MD, Program Director of Movement Disorders, Department of Neurology, Division of Medicine, Director of Neurology Residency Training Program, Cleveland Clinic Florida | Nothing to disclose | Details | | CME Editor | Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital | Nothing to disclose | Details | | Chief Editor | Nicholas Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Stephen T Gancher, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Nestor Galvez-Jimenez, Managing Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Matthew J Baker, CME Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Nicholas Y Lorenzo, Chief Editor |
The contributor discloses no conflict of interest. |
|